GEN | Solid Biosciences Licenses Use of Next-Generation Capsid AAV-SLB101 to Andelyn Biosciences

Please click here to be taken to the external linkDownload

News & Press Releases

Press Release

August 18, 2026

Andelyn Biosciences to Implement Curator® Platform to Develop and Manufacture Gene Therapy AAV9-GM2 for Queen’s University to Treat GM2 GangliosidosesAndelyn Biosciences to Implement Curator® Platform to Develop and Manufacture Gene Therapy AAV9-GM2 for Queen’s University to Treat GM2 Gangliosidoses
News

July 31, 2026

Ohio Life Sciences | National Security Commission on Emerging Biotechnology Visits Ohio as Part of “Biotech Across America” District Spotlight SeriesOhio Life Sciences | National Security Commission on Emerging Biotechnology Visits Ohio as Part of “Biotech Across America” District Spotlight Series
News

June 8, 2026

Contract Pharma | Cell & Gene Therapy CDMO Partnerships: Alliances and expertise behind advancing CGTs in today’s market.Contract Pharma | Cell & Gene Therapy CDMO Partnerships: Alliances and expertise behind advancing CGTs in today’s market.
News

May 18, 2026

Manufacturing Chemist | Andelyn Biosciences strengthens CDMO credentials with full ICMC certificationManufacturing Chemist | Andelyn Biosciences strengthens CDMO credentials with full ICMC certification
View All News & Press Releases
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
PreferencesDenyAccept